Expanding treatment eligibility for chronic hepatitis B: Balancing benefits, limitations, and healthcare access: Correspondence to editorial on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from th

Their thoughtful remarks not only highlight the complexities of managing chronic hepatitis B (CHB) with currently available antiviral therapies but also put our findings into perspective regarding inequalities in the burden of hepatitis B virus (HBV) around the world.We firmly believe that such active dialogue is critical as we strive toward eliminating HBV as a global public health threat.Below, we